Stratified Medicines, Drug Safety and Systems Pharmacology: providing the impetus for Clinical Pharmacology research

This innovative Clinical Fellowship scheme is funded by the MRC and seeks to develop the Clinical Pharmacology assets required by the UK.

The programme takes advantage of a range of resources at both the University of Liverpool, and the University of Manchester.  It is supported by industry expertise and operates across a broad range of therapeutic areas while focussed on the cross-cutting themes of drug safety, stratified medicine and systems pharmacology.

Themes diagram

Utilising the combined strengths of the Universities, the programme focuses on the broad themes of Stratified Medicine, Drug Safety and Systems Pharmacology in the clinical areas of:

  • Oncology
  • Infectious diseases
  • Inflammation and repair (e.g. respiratory medicine, inflammatory skin disease, diabetes, endocrine sciences).

‌We draw heavily on the renowned training of the Department of Molecular and Clinical Pharmacology at the University of Liverpool, with its seamless working relationship between clinical and basic pharmacologists.

A significant strength of the programme is the linkage with organ specialties and themes in both universities. This provides trainees with:

  • Access to patients with a variety of diseases
  • Access to clinical research facilities (at the Royal Liverpool Hospital and the Wellcome Trust Clinical Research Facility in Manchester)
  • Access to accredited clinical trials units
  • Access to state-of-the-art technologies and research facilities in industry.

Back to: North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics